Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members
View by type:
Documents (9899)
Showing 12 of 9899
View All
Showing 753 of 825 pages
B Programme update country programmes pdf
1
Report to the
GAVI Alliance Board
Board -2012 -Mtg -2-Doc B
12 -13 June 2012
Subject : Programme update: country programmes
Report of: Paul Kelly, Director, Country Support , and
Bakhuti Shengelia, Director, Technical Coordination
Authored by: Paul Kelly and Bakhuti Shengelia
Agenda item : B
Category: For Information
Strategic goal : SG1, SG2, SG3
Section A: Overview
1. Purpose of the repor t
1.1 To update on implementation of GAVI country programmes since reporting to
the Board in November 2011.
2. Recommendations
2.1 This report is for information.
3. Executive summary
3.1 Good progress is being made in India and Nigeria. Pentavalent vaccine has
now been introduced in two states in December 2011 in India and in January
2012 GAVI received a request to scale -up to an additional six states. Nigeria?s
National Vaccine Summit in April has focused high level atte ntion on the
phase -in of pentavalent and pneumococcal vaccines. This will be supported
by reprogramming of GAVI HSS and ISS funds (up to $ 60m in total ) and
targeting of potential new funding (to the tune of US$ 40 million) until the
country graduates .
3.2 Alliance partners are working closely with DRC, Ethiopia and Pakistan to
support them to manage significant implementation challenges related t o
introducing and sustaining new vaccine s. DRC paid its 2010 co -financing
arrears in May 2012 and intends to pay the 2011 amount by June 201 2.
3.3 In February 2012, WHO, UNICEF and the Secretariat reviewed progress on
development of Alliance action plans to support countries achieve and
maintain DTP3 coverage above 70%. WHO will prioritise work in Chad , DRC
and Uganda and finalise plans in Q3 of 2012 .
Report to the
GAVI Alliance Board
Board -2012 -Mtg -2-Doc B
12 -13 June 2012
Subject : Programme update: country programmes
Report of: Paul Kelly, Director, Country Support , and
Bakhuti Shengelia, Director, Technical Coordination
Authored by: Paul Kelly and Bakhuti Shengelia
Agenda item : B
Category: For Information
Strategic goal : SG1, SG2, SG3
Section A: Overview
1. Purpose of the repor t
1.1 To update on implementation of GAVI country programmes since reporting to
the Board in November 2011.
2. Recommendations
2.1 This report is for information.
3. Executive summary
3.1 Good progress is being made in India and Nigeria. Pentavalent vaccine has
now been introduced in two states in December 2011 in India and in January
2012 GAVI received a request to scale -up to an additional six states. Nigeria?s
National Vaccine Summit in April has focused high level atte ntion on the
phase -in of pentavalent and pneumococcal vaccines. This will be supported
by reprogramming of GAVI HSS and ISS funds (up to $ 60m in total ) and
targeting of potential new funding (to the tune of US$ 40 million) until the
country graduates .
3.2 Alliance partners are working closely with DRC, Ethiopia and Pakistan to
support them to manage significant implementation challenges related t o
introducing and sustaining new vaccine s. DRC paid its 2010 co -financing
arrears in May 2012 and intends to pay the 2011 amount by June 201 2.
3.3 In February 2012, WHO, UNICEF and the Secretariat reviewed progress on
development of Alliance action plans to support countries achieve and
maintain DTP3 coverage above 70%. WHO will prioritise work in Chad , DRC
and Uganda and finalise plans in Q3 of 2012 .
GAVI Alliance Board Minutes 12 13 June 2012 pdf
GAVI Alliance Board Meeting
12-13 June 2012
Board-2012-Mtg-2 1
GAVI Alliance Board Meeting
12-13 June 2012
Washington, DC, USA
FINAL MINUTES
1. Chair?s report and consent agenda
Chair?s report
1.1 Finding a quorum of members present, the meetin g commenced at 9.02
Washington time on 12 June 2011. Dagfinn H?ybr?ten, Board Chair, chaired
the meeting.
1.2 The Chair opened the meeting by referencing the Norwegian concept of a
?dugnad,? which he explained was a group of people who come together to
solve problems for the common good. He observed tha t this Board was a
dugnad, and encouraged Board members to engage with each other in that
spirit.
1.3 The Chair referenced the Child Survival Call to Action organised by USAID,
UNICEF, and the governments of India and Ethiopia t o be held at Georgetown
University on 14-15 June 2012. He also announced th e publication of the
GAVI 2011 progress report, noting that a special on line edition was available.
He reminded the Board that 2011 had been a successf ul year: routine
immunisation rates reached 80%, the Board hired a n ew CEO, and GAVI met
its funding challenge. Now the Chair declared GAVI must ?deliver, deliver,
deliver? on the promises made at the pledging confe rence in June 2011.
1.4 Standing declarations of interest were tabled t o the Board (Doc 1a in the
Board pack). Alan Hinman noted that the Novartis re search grant reported in
Doc 1a was for rabies rather than measles. However, he declared an interest
in the measles decision since he leads a project th at works with the Measles-
Rubella Initiative (MR Initiative). He would recuse himself from that item. Anne
Schuchat reported that the US Centers for Disease C ontrol is involved with
some of the special studies to be discussed at this meeting and in the MR
Initiative; she would recuse herself from those mat ters. Nicholas Alipui and
Simon Bland declared they had no financial/personal interests in any of the
matters to be discussed at this meeting; so their o nly interests were in matters
involving UNICEF and DFID, respectively. Maria C. F reire declared interests
in any matters involving the Lasker Foundation (whe re she serves as
president) or Johns Hopkins University (where a fam ily member is employed),
Debbie Adams
Consent agenda
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Decision 1: Board and Committee member
appointments (1/4)
1
The GAVI Alliance Board :
? Appointed the following member to the Audit and Finance
Committee effective immediately and until the committees
are refreshed for the 2013 year :
? Yifei Li
Consent agenda
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Decision 1: Board and Committee member
appointments (1/4)
1
The GAVI Alliance Board :
? Appointed the following member to the Audit and Finance
Committee effective immediately and until the committees
are refreshed for the 2013 year :
? Yifei Li
Seth Berkley MD
CEO
CEO Board report
GAVI Alliance Board meeting
Washington DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Overview of presentation
? New results
? Accelerated activities
? Expenditure and resources ? horizon view
? Opportunities and challenges
? Board agenda: key decisions and themes for
discussion
1
CEO
CEO Board report
GAVI Alliance Board meeting
Washington DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Overview of presentation
? New results
? Accelerated activities
? Expenditure and resources ? horizon view
? Opportunities and challenges
? Board agenda: key decisions and themes for
discussion
1
Wayne Berson
Audit and Finance Committee
Chair Report
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Activity since November 2011 Board meeting
? 1 video/teleconference meeting
? Areas reviewed:
1. Financial reporting and audit
2. Financial forecast / programme approvals /
programme funding policy amendment
3. Report of the Internal Auditor
4. Currency hedging
5. Risk management
6. Legal matters
1
Audit and Finance Committee
Chair Report
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Activity since November 2011 Board meeting
? 1 video/teleconference meeting
? Areas reviewed:
1. Financial reporting and audit
2. Financial forecast / programme approvals /
programme funding policy amendment
3. Report of the Internal Auditor
4. Currency hedging
5. Risk management
6. Legal matters
1
04 Financial Forecast presentation pdf
Barry Greene
Financial forecast
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Projected demand
1
Includes the new
vaccine windows
(MR, HPV, JE, typhoid)
Prior to any other
new vaccines (and
measles option)
Includes VIG policy
change - the main
difference since last
forecast
2011 -15 : $8.0 bn
2016 -20: $7.9 bn
Indicative
Financial forecast
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Projected demand
1
Includes the new
vaccine windows
(MR, HPV, JE, typhoid)
Prior to any other
new vaccines (and
measles option)
Includes VIG policy
change - the main
difference since last
forecast
2011 -15 : $8.0 bn
2016 -20: $7.9 bn
Indicative
05 Report of internal auditor pdf
Cees Klumper
Report of the internal auditor
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Topics for discussion
1
? R isk management:
? The process
? Cash support
? Vaccine support
? Investigations update
? Priorities for the coming year
Report of the internal auditor
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Topics for discussion
1
? R isk management:
? The process
? Cash support
? Vaccine support
? Investigations update
? Priorities for the coming year
06 Amendment to Programme Funding Policy pdf
Barry Greene
Amendment to the
Programme Funding Policy
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012 ~
GAVI Alliance Board meeting
12 -13 June 2012
Background
? Opportunity to streamline processes
? ?Rolling? basis for HSFP proposals from 2012
? requires more frequent funding allotments
? Need for timely operational adjustments to
budgets ? between committee meetings
? Essential to maintain due governance
? while improving operational efficiency
1
Amendment to the
Programme Funding Policy
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012 ~
GAVI Alliance Board meeting
12 -13 June 2012
Background
? Opportunity to streamline processes
? ?Rolling? basis for HSFP proposals from 2012
? requires more frequent funding allotments
? Need for timely operational adjustments to
budgets ? between committee meetings
? Essential to maintain due governance
? while improving operational efficiency
1
Helen Evans
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
Business planning process and risk
management update
GAVI Alliance Board meeting
12 ?13 June 2012
Business Plan 2013 ? 1 4 process
1
June
Board
Define high level priorities
for 2013 ?14
Dec
Board
Adjust business plan
and budget
1 2
? Each institution proposes
deliverables, activities and
budgets
? Coordination and feedback
provided by the Secretariat
? Review by External Advisory
Group
? Review by PPC, AFC
? Board approval
? Review the experience over
the first 2 years
? Interviews with many Board
members
? Workshops with Board
constituencies for
? SG 1, 2 & 3
? M & E
TODAY:
Validate
strategic priorities
Approve
Business Plan
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
Business planning process and risk
management update
GAVI Alliance Board meeting
12 ?13 June 2012
Business Plan 2013 ? 1 4 process
1
June
Board
Define high level priorities
for 2013 ?14
Dec
Board
Adjust business plan
and budget
1 2
? Each institution proposes
deliverables, activities and
budgets
? Coordination and feedback
provided by the Secretariat
? Review by External Advisory
Group
? Review by PPC, AFC
? Board approval
? Review the experience over
the first 2 years
? Interviews with many Board
members
? Workshops with Board
constituencies for
? SG 1, 2 & 3
? M & E
TODAY:
Validate
strategic priorities
Approve
Business Plan
08 Amendments to Statutes and By Laws presentation pdf
Debbie Adams
Amendments to Statutes
and By -Laws
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Decision 6: Amendments to Statutes and By -
Laws (1/3)
1
The GAVI Alliance Board :
? Amended By -Laws Article 3.1.1, clause 3 as follows:
? Up to eight additional Board Members (or Alternate
Board Members), who shall each be a voting member of
the Executive
Amendments to Statutes
and By -Laws
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Decision 6: Amendments to Statutes and By -
Laws (1/3)
1
The GAVI Alliance Board :
? Amended By -Laws Article 3.1.1, clause 3 as follows:
? Up to eight additional Board Members (or Alternate
Board Members), who shall each be a voting member of
the Executive
12 Options for enhancing GAVI s investment in measles prevention presentation pdf
Nina Schwalbe
Options for enhancing GAVI?s
investment in measles prevention
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Background and aim of increased GAVI
engagement
? Estimated measles mortality has plateaued around
140,000 deaths.
? Increased routine coverage critical to sustainably
controlling measles
? Outbreaks possible (e.g. every 3 ? 5 years) unless
coverage is high
? GAVI support:
? Long -term strategy for control in six countries
through high routine coverage
? outbreak prevention
Options for enhancing GAVI?s
investment in measles prevention
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Background and aim of increased GAVI
engagement
? Estimated measles mortality has plateaued around
140,000 deaths.
? Increased routine coverage critical to sustainably
controlling measles
? Outbreaks possible (e.g. every 3 ? 5 years) unless
coverage is high
? GAVI support:
? Long -term strategy for control in six countries
through high routine coverage
? outbreak prevention
13 Vaccine introduction grants and operational support for campaigns presentation pdf
Aur?lia Nguyen
Vaccine introduction grants and
operational support for campaigns
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Background: Vaccine introduction grants
1
? Until March 2012, GAVI had disbursed ~ 150 vaccine
introduction grants (US$ 28.6m total).
2001 2007 2011 ?12
US$ 100,000 lump
sum for all countries
Revised policy : US$ 100,000 or
US$ 0.30/child in birth cohort
Policy under review to better
serve newer vaccines
e.g. Kiribati Bangladesh
$ $
$
$
?
Newer vaccines: pneumococcal,
rotavirus, HPV , rubella
campaigns
e.g. Kiribati Bangladesh
Vaccine introduction grants and
operational support for campaigns
GAVI Alliance Board meeting
Washington, DC, USA, 12 -13 June 2012
GAVI Alliance Board meeting
12 -13 June 2012
Background: Vaccine introduction grants
1
? Until March 2012, GAVI had disbursed ~ 150 vaccine
introduction grants (US$ 28.6m total).
2001 2007 2011 ?12
US$ 100,000 lump
sum for all countries
Revised policy : US$ 100,000 or
US$ 0.30/child in birth cohort
Policy under review to better
serve newer vaccines
e.g. Kiribati Bangladesh
$ $
$
$
?
Newer vaccines: pneumococcal,
rotavirus, HPV , rubella
campaigns
e.g. Kiribati Bangladesh